Phase II study of pertuzumab, trastuzumab, and weekly paclitaxel in patients with HER2-overexpressing metastatic breast cancer (MBC) Meeting Abstract


Authors: Datko, F. M.; D'Andrea, G.; Dickler, M. N.; Goldfarb, S. B.; Theodoulou, M.; Lake, D.; Fornier, M. N.; Modi, S.; Fasano, J.; Comen, E. A.; Gajria, D.; Moynahan, M. E.; Traina, T. A.; Chen, M.; Hamilton, N.; Patil, S.; Chandarlapaty, S.; Hudis, C.; Dang, C. T.
Abstract Title: Phase II study of pertuzumab, trastuzumab, and weekly paclitaxel in patients with HER2-overexpressing metastatic breast cancer (MBC)
Meeting Title: 49th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 31
Issue: 15 Suppl.
Meeting Dates: 2013 May 31-Jun 4
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2013-05-20
Language: English
ACCESSION: WOS:000335419600111
PROVIDER: wos
Notes: Meeting Abstract: 606 -- Source: Wos
MSK Authors
  1. Sujata Patil
    382 Patil
  2. Clifford Hudis
    838 Hudis
  3. Chau Dang
    156 Dang
  4. Diana E Lake
    70 Lake
  5. Maura N Dickler
    237 Dickler
  6. Farrah Mikhail Datko
    8 Datko
  7. Monica Nancy Fornier
    136 Fornier
  8. Devika Gajria
    23 Gajria
  9. Elizabeth Comen
    46 Comen
  10. Tiffany A Traina
    153 Traina
  11. Shanu Modi
    132 Modi
  12. Julie Fasano
    9 Fasano
  13. Melanie Fanny Chen
    6 Chen